Skip to main content
. 2013 Dec 4;9:491–504. doi: 10.2147/TCRM.S52078

Table 4.

Weighted utility scores and total utility scores

Assigned weight
15.9
16.7
8.60
10.0
7.60
4.30
5.50
1.70
5.00
3.30
4.30
17.1


Factors Efficacy Medium/long-term effect Drug interaction Serious SE Documentation Formulations Indications Dose frequency Frequent SE Interaction with food Dose adjustments Cost TUS without cost TUS (all)
Pravastatin 9.23 13.22 7.15 9.03 6.84 3.87 4.40 1.70 4.41 3.30 3.01 15.97 66.15 82.13
Simvastatin 11.59 14.17 4.60 7.76 7.60 3.87 5.50 1.70 3.64 2.31 3.01 16.70 66.40 83.11
Lovastatin 10.17 13.22 5.09 9.–03 6.08 3.87 4.40 1.70 4.80 2.31 3.01 17.09 64.34 81.43
Atorvastatin 12.78 14.17 6.72 6.19 6.84 3.87 5.50 1.70 3.39 3.30 3.44 16.58 67.89 84.48
Rosuvastatin 13.72 10.06 7.54 9.46 6.08 3.87 5.50 1.70 3.05 3.30 3.01 12.33 67.30 79.63
Fluvastatin 9.23 11.32 7.29 9.03 6.08 4.30 4.40 1.70 3.93 3.30 3.01 7.26 63.60 70.86

Abbreviations: TUS, total utility score; SE, side effects.